Pulmonx (LUNG) News Today $6.28 +0.08 (+1.29%) (As of 10:38 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Pulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 20 at 4:20 PM | globenewswire.comPulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersNovember 19 at 10:57 AM | finance.yahoo.comPulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 7, 2024 | markets.businessinsider.comPulmonx (LUNG) Gets a Buy from Stifel NicolausNovember 6, 2024 | markets.businessinsider.comPulmonx to Present at the Stifel 2024 Healthcare ConferenceNovember 5, 2024 | globenewswire.comPulmonx Corporation’s Financial Stability at Risk Amid Product and Market ChallengesNovember 3, 2024 | msn.comHere's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter ResultsNovember 2, 2024 | finance.yahoo.comPiper Sandler Remains a Buy on Pulmonx (LUNG)November 1, 2024 | markets.businessinsider.comPulmonx price target lowered to $10 from $12 at Piper SandlerNovember 1, 2024 | markets.businessinsider.comPulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...October 31, 2024 | finance.yahoo.comPulmonx Corporation Reports Solid Revenue Growth in Q3 2024October 31, 2024 | markets.businessinsider.comPulmonx (NASDAQ:LUNG) Stock Quotes, Forecast and News SummaryOctober 29, 2024 | benzinga.comEarnings Preview For PulmonxOctober 29, 2024 | benzinga.comPulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have received a consensus rating of "Moderate Buy" from the six brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to thOctober 29, 2024 | marketbeat.comPulmonx (LUNG) Set to Announce Quarterly Earnings on WednesdayPulmonx (NASDAQ:LUNG) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=465680)October 23, 2024 | marketbeat.comInsider Selling: Pulmonx Co. (NASDAQ:LUNG) Director Sells 20,000 Shares of StockOctober 22, 2024 | insidertrades.comPulmonx Co. (NASDAQ:LUNG) Director Sells $130,400.00 in StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) Director Glendon E. French III sold 20,000 shares of the stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $6.52, for a total value of $130,400.00. Following the sale, the director now owns 1,091,974 shares in the company, valued at approximately $7,119,670.48. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.October 21, 2024 | marketbeat.comPulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024October 16, 2024 | globenewswire.comMillennium Management LLC Trims Holdings in Pulmonx Co. (NASDAQ:LUNG)Millennium Management LLC decreased its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 31.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 448,623 shares of the company's stock after selling 201,6October 15, 2024 | marketbeat.comSquarepoint Ops LLC Purchases 104,432 Shares of Pulmonx Co. (NASDAQ:LUNG)Squarepoint Ops LLC lifted its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 261.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 144,409 shares of the company's stock after purchasing an addiOctober 7, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from AnalystsPulmonx Co. (NASDAQ:LUNG - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The aOctober 4, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Position Lessened by Point72 Asset Management L.P.Point72 Asset Management L.P. reduced its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 91.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 240,949 shares of thOctober 4, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Director Sells $161,800.00 in StockSeptember 19, 2024 | insidertrades.comWells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)September 10, 2024 | markets.businessinsider.comPulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024September 9, 2024 | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have received an average rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating toSeptember 9, 2024 | marketbeat.comGeoffrey Beran Rose Sells 4,586 Shares of Pulmonx Co. (NASDAQ:LUNG) StockSeptember 6, 2024 | insidertrades.comPulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 4,586 SharesPulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 4,586 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $6.70, for a total transaction of $30,726.20. Following the completion of the sale, the insider now owns 295,433 shares in the company, valued at $1,979,401.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link.September 5, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Short Interest Down 8.2% in AugustPulmonx Co. (NASDAQ:LUNG - Get Free Report) saw a significant decline in short interest in August. As of August 15th, there was short interest totalling 1,450,000 shares, a decline of 8.2% from the July 31st total of 1,580,000 shares. Currently, 4.1% of the company's stock are sold short. Based on an average daily volume of 369,800 shares, the days-to-cover ratio is currently 3.9 days.September 2, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Buys 69,595 Shares of Pulmonx Co. (NASDAQ:LUNG)BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 7.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,059,018 shares of the company'sSeptember 1, 2024 | marketbeat.comAeriseal’s Market Potential and Safety Profile: Justifying a Hold Rating for PulmonxAugust 31, 2024 | markets.businessinsider.comPulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceAugust 29, 2024 | finance.yahoo.comSteven S. Williamson Acquires 14,245 Shares of Pulmonx Co. (NASDAQ:LUNG) StockAugust 23, 2024 | insidertrades.comInsider Buying: Pulmonx Co. (NASDAQ:LUNG) CEO Acquires 14,245 Shares of StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) CEO Steven S. Williamson acquired 14,245 shares of the company's stock in a transaction dated Tuesday, August 20th. The stock was acquired at an average cost of $6.84 per share, with a total value of $97,435.80. Following the purchase, the chief executive officer now owns 219,531 shares of the company's stock, valued at $1,501,592.04. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.August 22, 2024 | marketbeat.comPulmonx to Present at the 2024 Wells Fargo Healthcare ConferenceAugust 22, 2024 | globenewswire.comBuy Rating Affirmed for Pulmonx: Strong Growth and Promising Clinical AdvancementsAugust 15, 2024 | markets.businessinsider.comPulmonx stock hits 52-week low at $5.67 amid market challengesAugust 7, 2024 | uk.investing.comAnalysts Are Updating Their Pulmonx Corporation (NASDAQ:LUNG) Estimates After Its Second-Quarter ResultsAugust 2, 2024 | finance.yahoo.comCanaccord Genuity Group Raises Pulmonx (NASDAQ:LUNG) Price Target to $16.00Canaccord Genuity Group upped their target price on Pulmonx from $15.00 to $16.00 and gave the company a "buy" rating in a research report on Thursday.August 1, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) Given New $10.00 Price Target at Wells Fargo & CompanyWells Fargo & Company reduced their price objective on Pulmonx from $14.00 to $10.00 and set an "equal weight" rating on the stock in a research note on Thursday.August 1, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Has $1.83 Million Stock Position in Pulmonx Co. (NASDAQ:LUNG)Jacobs Levy Equity Management Inc. reduced its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 45.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 197,336 shares of the company's stock after selling 1August 1, 2024 | marketbeat.comPulmonx Reports Second Quarter 2024 Financial ResultsJuly 31, 2024 | globenewswire.comPulmonx to Present at the Canaccord Genuity 44th Annual Growth ConferenceJuly 29, 2024 | globenewswire.comPulmonx Corporation (LUNG)July 26, 2024 | finance.yahoo.comPulmonx (LUNG) Scheduled to Post Earnings on WednesdayPulmonx (NASDAQ:LUNG) will be releasing earnings after the market closes on Wednesday, July 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=465680)July 24, 2024 | marketbeat.comPulmonx: Low Bar For Q2 EarningsJuly 21, 2024 | seekingalpha.comPulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesPulmonx Co. (NASDAQ:LUNG - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seven research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the comJuly 21, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Short Interest Down 14.3% in JunePulmonx Co. (NASDAQ:LUNG - Get Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,200,000 shares, a drop of 14.3% from the June 15th total of 1,400,000 shares. Approximately 3.4% of the shares of the company are short sold. Based on an average trading volume of 436,600 shares, the days-to-cover ratio is presently 2.7 days.July 14, 2024 | marketbeat.comPulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024July 10, 2024 | globenewswire.comBraidwell LP Sells 200,605 Shares of Pulmonx Co. (NASDAQ:LUNG)Braidwell LP reduced its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 20.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 787,954 shares of the company's stock after selling 200,605 shares during the period. Braidwell LP owned approximatelyJune 12, 2024 | marketbeat.com Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. LUNG Media Mentions By Week LUNG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUNG News Sentiment▼0.000.46▲Average Medical News Sentiment LUNG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUNG Articles This Week▼22▲LUNG Articles Average Week Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cerus News Today Inovio Pharmaceuticals News Today Atrion News Today Pulse Biosciences News Today Bioventus News Today CeriBell News Today National Vision News Today Paragon 28 News Today Liquidia News Today Avanos Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUNG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
